Schizophrenia and cell senescence candidate genes screening, machine learning, diagnostic models, and drug prediction

Yu Feng1,2,3, Jing Shen1, Jin He1

  • 1The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Suzhou, China.

Abstract

Insights

This study identified six candidate genes linked to cell senescence that show diagnostic significance for schizophrenia. These findings offer potential new avenues for diagnosing and treating this complex psychiatric disorder.

Area of Science:

  • Genetics
  • Immunology
  • Psychiatry

Background:

  • Schizophrenia (SC) is a common psychiatric disorder with unclear genetic underpinnings and treatment options.
  • Cellular senescence is implicated in mental diseases, with links to immunity and suicide risk in schizophrenia patients.

Purpose of the Study:

  • To identify candidate genes associated with cellular senescence relevant to schizophrenia diagnosis and treatment.
  • To explore the role of immune-related genes in schizophrenia pathogenesis.

Main Methods:

  • Utilized Gene Expression Omnibus (GEO) datasets for schizophrenia (training and validation).
  • Integrated cell senescence genes from CellAge database with differentially expressed genes (DEGs) from schizophrenia datasets.
  • Employed weighted gene co-expression network analysis (WGCNA), LASSO regression, and Random Forest for gene identification and validation.
  • Analyzed immune cell infiltrates and utilized Receiver Operating Characteristic (ROC) curves for diagnostic assessment.

Main Results:

  • Identified six candidate genes (SFN, KDM5B, MYLK, IRF3, IRF7, ID1) with significant diagnostic value for schizophrenia.
  • Confirmed high diagnostic accuracy using ROC curve analysis.
  • Identified Fostamatinib and Ritodine as potential drugs targeting the candidate genes.

Conclusions:

  • Six candidate genes demonstrate diagnostic significance for schizophrenia, potentially aiding in early detection.
  • The findings provide evidence for the role of cell senescence and immune dysregulation in schizophrenia pathogenesis.
  • Fostamatinib is highlighted as a potential therapeutic agent for schizophrenia, particularly in cases involving immune thrombocytopenic purpura.